TATaize Machado Augusto

Taize Machado Augusto

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Taize Machado Augusto has a total of 61 co-authors. Here are the top co-authors by number of shared publications:

  • Hernandes Faustino Carvalho

    Department of Structural and Functional Biology, State University of Campinas, Campinas, SP, Brazil

    4 shared publications
  • A. Bruni‐Cardoso

    Department of Anatomy, Cell Biology, Physiology and Biophysics, Institute of Biology, Universidade Estadual de Campinas, Campinas, São Paulo, SP, Brazil

    2 shared publications
  • D. M. Damas‐Souza

    Department of Anatomy, Cell Biology, Physiology and Biophysics, Institute of Biology, Universidade Estadual de Campinas, Campinas, São Paulo, SP, Brazil

    2 shared publications
  • Guilherme Oliveira Barbosa

    Department of Biochemistry and Tissue Biology, Institute of Biology Universidade Estadual de Campinas São Paulo Brazil

    2 shared publications
  • Hernandes F. Carvalho

    Department of Structural and Functional Biology, State University of Campinas, Campinas, São Paulo, Brazil

    2 shared publications
  • A Bruni-Cardoso

    Department of Anatomy, Cell Biology, Physiology, and Biophysics, Institute of Biology, State University of Campinas (UNICAMP), SP, Brazil

    1 shared publication

Latest Publications

  • Open Access

    Perspectives on cancer and phytotherapy: an overview focusing on Polypodium leucotomos therapeutic properties

    by Pammela Araújo Lacerda, Liliane Marinho Ottoni Costa, Guilherme Cuoghi Bellato, Lucilene Lopes-Santos, Taize M Augusto, Nilva Karla Cervigne


  • Toll-like receptor 4 (TLR4) influences the glial reaction in the spinal cord and the neural response to injury following peripheral nerve crush

    by Patrícia Ribeiro, Mateus V. Castro, Matheus Perez, Luciana P. Cartarozzi, Aline B. Spejo, Gabriela B. Chiarotto, Taize M. Augusto, Alexandre L.R. Oliveira


  • Open Access

    An Overview on Prostate Pathophysiology: New Insights into Prostate Cancer Clinical Diagnosis

    by Gustavo Ferreira Simoes, Paula Sakuramoto, Caroline Brito dos Santos, Nilva Karla Cervigne Furlan, Taize Machado Augusto

    The prostate is an accessory gland of the male reproductive tract, and its presence is universal in mammals. It is committed to the prostatic fluid production and storage, which is released with other semen components during ejaculation. Such fluid contributes to increasing motility and fertility of the spermatozoa, and the neutralization of the vagina, thus playing an important role in fertilization. Few pathological complications, often progressively aggravated with age, can affect this gland (i.e. benign and malignant proliferative changes; all to be described next in this chapter). Nowadays, the neoplastic expansion is the main motivator and contributor for studies on enlightening of growth regulation mechanisms and physiology of the prostate.


  • Heparanase 1 involvement in prostate physiopathology

    by Guilherme O. Barbosa, Nilva K. Cervigne, Hernandes F. Carvalho, Taize M. Augusto

    The prostate is a compound exocrine gland of the male reproductive tract universally present in mammals. It is highly responsive to androgen and can be committed by a variety of pathological complications as prostatitis, benign, and malignant proliferative changes, which may be intensified by aging. Prostate intensively turnover its extracellular matrix (ECM) either at homeostasis or disease which includes a dynamically change of glycosaminoglycan composition during the life of an individual. Among the different enzymes playing a role in such changes, heparanase‐1 is responsible for cleaving heparan sulfate (HS) at a limited number of sites, clearly involved in tissue remodeling. Its activity has been strongly implicated in cell invasion associated with cancer metastasis, a consequence of the structural modification that loosens the ECM barrier. In the present review we focuses in some aspects of the prostate physiology and diseases, particular prostate cancer, evidencing how the HPSE‐1 activity encompasses the relationship of both processes.


  • Open Access

    Menthol Inhibits Detrusor Contractility Independently of TRPM8 Activation

    by Antonio Celso Saragossa Ramos-Filho, Ajay Shah, Taize Machado Augusto, Guilherme Oliveira Barbosa, Luiz Osorio Leiria, Hernandes Faustino de Carvalho, Edson Antunes, Andrew Douglas Grant

    Agonists such as icilin and menthol can activate the cool temperature-sensitive ion channel TRPM8. However, biological responses to menthol may occur independently of TRPM8 activation. In the rodent urinary bladder, menthol facilitates the micturition reflex but inhibits muscarinic contractions of the detrusor smooth muscle. The site(s) of TRPM8 expression in the bladder are controversial. In this study we investigated the regulation of bladder contractility in vitro by menthol. Bladder strips from wild type and TRPM8 knockout male mice (25–30 g) were dissected free and mounted in organ baths. Isometric contractions to carbachol (1 nM–30 µM), CaCl2 (1 µM to 100 mM) and electrical field stimulation (EFS; 8, 16, 32 Hz) were measured. Strips from both groups contracted similarly in response to both carbachol and EFS. Menthol (300 µM) or nifedipine (1 µM) inhibited carbachol and EFS-induced contractions in both wild type and TRPM8 knockout bladder strips. Incubation with the sodium channel blocker tetrodotoxin (1 µM), replacement of extracellular sodium with the impermeant cation N-Methyl-D-Glucamine, incubation with a cocktail of potassium channel inhibitors (100 nM charybdotoxin, 1 µM apamin, 10 µM glibenclamide and 1 µM tetraethylammonium) or removal of the urothelium did not affect the inhibitory actions of menthol. Contraction to CaCl2 was markedly inhibited by either menthol or nifedipine. In cultured bladder smooth muscle cells, menthol or nifedipine abrogated the carbachol or KCl-induced increases in [Ca2+]i. Intravesical administration of menthol increased voiding frequency while decreasing peak voiding pressure. We conclude that menthol inhibits muscarinic bladder contractions through blockade of L-type calcium channels, independently of TRPM8 activation.


  • Neonatal exposure to high doses of 17β-estradiol results in inhibition of heparanase-1 expression in the adult prostate

    by Taize M. Augusto, Rafaela Rosa-Ribeiro, Hernandes F. Carvalho

    Heparanase-1 (HPSE-1) is an endoglycosidase that cleaves heparan sulfate. The physiological functions of HPSE-1 include embryo development, hair growth, wound healing, tumor growth, angiogenesis, metastasis, and inflammation. HPSE-1 expression was found to increase temporarily in the rat ventral prostate (VP) after castration. The promoter region of the Hpse-1 gene has estrogen-responsive elements, suggesting that the gene is regulated by estrogens. In this study, we investigated the expression of HPSE-1 in the VP of 90-day-old rats after neonatal exposure to a high dose of 17β-estradiol. HPSE-1 was not found by immunohistochemistry in the epithelium of estrogenized animals. To determine whether inhibition of Hpse-1 expression in the epithelium was due to pre- or post-transcriptional regulation, epithelial cells were isolated by centrifugation in Percoll gradient and the presence of Hpse-1 mRNA was investigated by RT-PCR. Hpse-1 mRNA was not detected in the estrogenized animals. Considering that Hpse-1 transcription could be inhibited by DNA methylation, we used the methylation-sensitive restriction enzyme HpaII and PCR to show that a single CCGG site at position +185 was more frequently methylated in the epithelium of estrogenized than in control animals. Immunohistochemistry for 5-methylcytidine revealed that the epithelial cell nuclei in estrogenized animals were heavily methylated. These results suggest that Hpse-1 expression was blocked in the epithelial cells of the VP, by estrogen imprinting by a pre-transcriptional mechanism involving DNA methylation.


  • Open Access

    The anti‐oestrogen fulvestrant (ICI 182,780) reduces the androgen receptor expression, ERK1/2 phosphorylation and cell proliferation in the rat ventral prostate

    by S. A. F. Fernandes, G. R. O. Gomes, E. R. Siu, D. M. Damas‐Souza, A. Bruni‐Cardoso, T. M. Augusto, M. F. M. Lazari, H. F. Carvalho, C. S. Porto

    Summary: This study proposed to investigate further the role of oestrogens during pubertal growth of rat ventral prostate, by analysing the effect of anti‐oestrogen fulvestrant (ICI 182,780) on the expression of androgen (AR) and oestrogen receptors (ESR1 and ESR2), mitogen‐activated protein kinase (ERK1/2) phosphorylation, and expression of Ki‐67, a biomarker for cell proliferation. Ventral prostates were obtained from 90‐day‐old rats treated once a week for 2 months with vehicle (control) or ICI 182,780 (10 mg/rat, s.c.). Transcripts for AR, ESR1 and ESR2 were evaluated by quantitative real‐time polymerase chain reaction. Expression of AR, ESR1, ESR2, total and phospho‐ERK1/2 was analysed by Western blot or immunofluorescence. Ki‐67‐positive cells and myosin heavy chain were detected by immunohistochemistry. Cylindrical epithelial cells slightly taller, epithelial dysplasia and an increase in smooth muscle layer were observed in the ventral prostate from ICI 182,780‐treated rats. ICI 182,780 did not change the mRNA, but decreased the protein levels for AR in the ventral prostate. The expression of ESR1 (mRNA and protein) was upregulated by ICI 182,780, but no changes were observed on ESR2 expression (mRNA and protein). ICI 182,780 decreased the phosphorylation state of ERK1/2, with no changes in total ERK1/2 levels. Ki‐67‐positive cells in the ventral prostate were also decreased by ICI 182,780. In conclusion, ICI 182,780 induces downregulation of AR expression and may block the translocation of ESR1 and ESR2 from the nucleus to the plasma membrane, decreasing ERK1/2 phosphorylation and prostatic epithelial cell proliferation. These findings provide a basis for physiological roles of oestrogen in the ventral prostate. Further studies with fulvestrant are necessary in benign prostate hyperplasia and prostatic cancer models.


  • Stromal remodelling is required for progressive involution of the rat ventral prostate after castration: Identification of a matrix metalloproteinase‐dependent apoptotic wave

    by A Bruni-Cardoso, T M Augusto, H Pravatta, D M Damas-Souza, H F Carvalho

    Summary: Prostate epithelial‐cell apoptosis occurs in response to androgen deprivation. We have hypothesized that continued regression would require stromal changes. Studying apoptosis kinetics up to the 14th day after castration, we identified successive waves of apoptosis, with a prominent peak on day 11. This peak was associated with caspase‐3 activity, nuclear translocation of apoptosis‐inducing factor and clusterin expression. The apoptosis peak on day 11 was preceded by increased MMP‐2 and MMP‐7 activation, and MMP‐9 expression on days 9 and 10. Treatment with the matrix metalloproteinases inhibitors doxycyclin, hydrocortisone, or GM6001 caused significant reduction in the apoptosis rate on day 11. The present data demonstrate that prostatic epithelial‐cell deletion at the 11th day after castration was induced by focal degradation of the extracellular matrix associated with stromal remodelling.


  • Open Access

    Oestrogen imprinting causes nuclear changes in epithelial cells and overall inhibition of gene transcription and protein synthesis in rat ventral prostate

    by T. M. Augusto, A. Bruni‐Cardoso, D. M. Damas‐Souza, W. F. Zambuzzi, F. Kühne, L. B. Lourenço, C. V. Ferreira, H. F. Carvalho

    Summary: Oestrogen exposure during the early post‐natal period affects male growth, physiology, and susceptibility to disease in adult life. The prostate gland is susceptible to this oestrogen imprinting, showing a reduced expression of the androgen receptor and inability to respond to androgen stimulus. In this context, we decided to study key signalling regulators of ventral prostate (VP) functioning after early postnatal exposure to high‐dose oestrogen. Our results showed a decrease of mTOR phosphorylation and its direct downstream target 4EBP. It is known that mTOR‐induced signalling is a pivotal pathway of cell metabolism, which is able to control gene transcription and protein synthesis. We then decided to investigate other indicators of a reduced metabolism in the oestrogenized prostate, and found that the luminal epithelial cells were shorter, less polarized and had smaller nuclei containing more compacted chromatin, suggesting that a general mechanism of regulating gene expression and protein synthesis could be installed in the epithelium of the oestrogenized VP. To evaluate this idea, we analysed nucleolar morphology, and measured the amount of ribosomes and the level of methylation of the 45S ribosomal RNA promoter region. These data indicated that the nucleolus was dismantled and that the methylation at the 45S promoter was increased (∼five‐fold). Taken together, the results support the idea that the oestrogenized prostate maintains a very low transcriptional level and protein turnover by affecting canonical signalling pathways and promoting nuclear and nucleolar changes.